Topic

Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.

Articles

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Moving Into the Next Phase

The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.

Acknowledging Bio/Pharma Innovation

Smart, accurate, science-based messaging is needed to advance bio/pharma science.

Avoiding Unforced Errors in the Bio/Pharma Industry

Editor of Pharmaceutical Technology Europe

COVID-19 has placed bio/pharma in the spotlight of global media, but away from vaccines there are other prospective pipeline treatments that will be worth watching.

A Watchful Eye on Pharma: Promising Drugs and Changing Bio/Pharma Landscape

Bio/pharma works hard today to change the calendar to tomorrow.

Fighting Through This Slow Season of Change

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.

Meeting CGT Demand

COVID-19 vaccine supplies are breaking news headlines, in both ‘good’ and ‘not so good’ ways.  

In Short Supply

A complicated vaccination rollout and mixed messages may derail the pandemic endgame.

A Hopeful but Dangerous Phase

The outlook for the European pharma industry is appearing to be favourable overall.

A Bright Outlook

Shutting down the COVID-19 pandemic requires a global, selfless effort.

From the Editor